我要投票 云南白药在保健养生行业中的票数:296
· 外 推 电 报 ·
2025-02-23 18:01:14 星期日

【云南白药是哪个国家的品牌?】

云南白药是什么牌子?「云南白药」是 云南白药集团股份有限公司 旗下著名品牌。该品牌发源于云南省昆明市,由创始人王明辉在1993-11-30期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力云南白药品牌出海!通过在本页面挂载云南白药品牌的产品链接和联系邮箱,可以提高云南白药产品曝光!跨境电商爆单神器,目前只要100元/年哦~

云南白药由云南民间名医曲焕章先生于1902年创制,问世百年来,以其神奇的疗效被世人誉之为“伤科圣药”、“中华瑰宝”。

1971年,公司前身云南白药厂正式成立,白药开始了专业化生产。公司于1993年在深交所挂牌上市,成为云南省第一家A股上市公司。1996年,公司分别投资控股原云南地州的三家云南白药生产企业,即云南大理州制药厂、云南文山州制药厂和云南丽江药业有限公司,共同组成云南白药集团,对云南白药的生产经营实行“五统一”,为名牌战略的实施奠定了基础。1997年公司经国家批准获得自营进出口权。1999年,红塔成为白药集团第二大股东,实现了股权多元化;同年,云南省医药公司和天紫红药厂以优质资产配股方式进入云南白药集团,集团产业链从生产制造延伸到了药品流通和饮片加工领域。目前,省医药公司已成功改组为云南省医药有限公司,在云南首家通过国家GSP认证。天紫红药厂已改制为云南白药集团原生药材事业部,作为省内唯一的饮片加工企业,已于2003年顺利通过国家GMP认证。

经过30多年的发展,公司已从一个资产不足300万元的生产企业成长为一个总资产22亿多,总销售收入逾32亿元,经营涉及化学原料药、化学药制剂、中成药、中药材、生物制品、保健食品、化妆品及饮料的研制、生产及销售;糖、茶,建筑材料,装饰材料的批发、零售、代购代销;科技及经济技术咨询服务,医疗器械(二类、医用敷料类、一次性使用医疗卫生用品),日化用品等领域的云南省实力最强、品牌最优的大型医药企业集团。公司产品以云南白药系列和田七系列为主,共十种剂型七十余个产品,主要销往国内、港澳、东南亚等地区,并已进入日本、欧美等国家、地区的市场。“云南白药”商标于2002年2月被国家工商行政管理总局商标局评为中国驰名商标。

英文翻译:Yunnan Baiyao was created in 1902 by Mr. Qu Huanzhang, a famous folk doctor in Yunnan Province. It has been known as "the holy medicine of Traumatology" and "the treasure of China" for its magical curative effect for more than 100 years. In 1971, Yunnan Baiyao factory, the predecessor of the company, was officially established and specialized production of Baiyao began. The company was listed on Shenzhen Stock Exchange in 1993 and became the first A-share listed company in Yunnan Province. In 1996, the company invested and controlled three Yunnan Baiyao production enterprises in the former Yunnan Prefecture, namely Yunnan Dalizhou pharmaceutical factory, Yunnan Wenshanzhou pharmaceutical factory and Yunnan Lijiang Pharmaceutical Co., Ltd. to jointly form Yunnan Baiyao group, which implemented "Five Unifications" for the production and operation of Yunnan Baiyao, laying a foundation for the implementation of the famous brand strategy. In 1997, the company obtained the right of self import and export with the approval of the state. In 1999, Hongta became the second largest shareholder of Baiyao group, realizing equity diversification; in the same year, Yunnan pharmaceutical company and Tianzi Hongyao factory entered Yunnan Baiyao group by way of high-quality asset allotment, and the industrial chain of the group extended from production and manufacturing to the field of drug circulation and processing of decoction pieces. At present, the provincial pharmaceutical company has been successfully restructured into Yunnan Pharmaceutical Co., Ltd., the first one in Yunnan to pass the national GSP certification. Tianzihong pharmaceutical factory has been transformed into Yunnan Baiyao Group's original medicine business department. As the only processing enterprise in the province, it has successfully passed the national GMP certification in 2003. After more than 30 years of development, the company has grown from a production enterprise with less than 3 million yuan of assets to a total asset of more than 2.2 billion yuan, with a total sales revenue of more than 3.2 billion yuan. Its business involves the research, production and sales of chemical raw materials, chemical pharmaceutical preparations, Chinese patent medicines, biological products, health food, cosmetics and drinks; It is a large pharmaceutical enterprise group with the strongest strength and the best brand in Yunnan Province in the fields of sugar, tea, building materials, decoration materials wholesale, retail, purchasing and selling on behalf of others; scientific and technological and economic and technological consulting services, medical devices (class II, medical dressings, disposable medical and health products), daily chemical products, etc. The company's products are mainly Yunnan Baiyao series and Tianqi series, with a total of more than 70 dosage forms, which are mainly sold to domestic, Hong Kong, Macao, Southeast Asia and other regions, and have entered the markets of Japan, Europe and the United States and other countries and regions. "Yunnan Baiyao" trademark was awarded as China's well-known trademark by the Trademark Office of the State Administration for Industry and Commerce in February 2002.

本文链接: https://www.waitui.com/brand/7cc1e882e.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

天岳先进:2024年净利润1.8亿元 同比扭亏为盈

36氪获悉,天岳先进发布业绩快报,公司2024年实现营业收入17.68亿元,同比增长41.37%;实现归属于母公司所有者的净利润1.80亿元,同比扭亏为盈。主要原因是公司大尺寸、导电型产品产能产量持续提升,销售量增加,同时产品毛利率上升。

2分钟前

小米集团卢伟冰:小米15 Ultra会是越级式的一代产品

36氪获悉,小米集团合伙人兼总裁、手机部总裁、小米品牌总经理卢伟冰发文称,小米手机未来5年高端化的目标之一,就是要在6000元+价格段实现规模化的突破,“Ultra是6K+突破的关键产品,而小米15 Ultra会是越级式的一代产品”。

2分钟前

恒瑞医药:羟乙磺酸达尔西利片联合内分泌治疗乳腺癌III期临床试验达主要终点

36氪获悉,恒瑞医药公告称,公司自主研发的羟乙磺酸达尔西利片在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性女性乳腺癌辅助治疗的III期临床试验中,首次期中分析主要终点达到统计学显著性。研究结果显示,达尔西利联合内分泌治疗可显著降低患者复发风险,提高患者无侵袭性疾病生存期(IDFS)。公司已向国家药品监督管理局药品审评中心递交上市前沟通交流申请。该药品是公司自主研发的化学药品1类新药,是一种口服、高效、选择性的小分子CDK4/6抑制剂。

2分钟前

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

2分钟前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2分钟前

本页详细列出关于森山的品牌信息,含品牌所属公司介绍,森山所处行业的品牌地位及优势。
咨询